BCL2 and non-Hodgkin lymphoma: The specificity of the C. burnetii associated NHL transcriptomic signature was supported by gene expression analysis of the NHL control group, in which MIR17HG, SP100, REL, and ETS1 were not upmodulated, whereas BCL2 was significantly highly expressed (Fig 3C and 3D).